Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Allele Frequency–Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors

PaperCitations, authors & open-access status

Allele Frequency–Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 94 citations, 2019 year and bronze oa status.

94
Citations
2019
Year
bronze
OA Status

Related on ScholarIQ

Wenxian Wang
Author
Journal of Thoracic Oncology
Journal
Cancer Genomics and Diagnostics
Topic
Cancer Genomics and Diagnostics
Topic
Cancer Immunotherapy and Biomarkers
Topic
Pancreatic and Hepatic Oncology Research
Topic
470M+ articles · free account